Clinical Trial

A Prospective Database of Infants With Cholestasis

Study acronym: PROBE
Recruiting
View on ClinicalTrials.gov →
Summary
Biliary atresia, idiopathic neonatal hepatitis, and specific genetic cholestatic conditions are the most common causes of jaundice and hyperbilirubinemia that continue beyond the newborn period. The long term goal of the Childhood Liver Disease Research Network (ChiLDReN) is to establish a database of clinical information and plasma, serum, and tissue samples from cholestatic children to facilitate research and to perform clinical, epidemiological and therapeutic trials in these important pediatric liver diseases.
Protocol Amendment History 34 amendments
This ClinicalTrials.gov record has been amended 34 times since 2005-06-23; most recent amendment 2026-06-03.
Status change: Suspended → Recruiting 2021-04-21
Status change: Recruiting → Suspended 2020-04-01
Trial Details
NCT Number NCT00061828
Lead Sponsor Arbor Research Collaborative for Health
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Biliary Atresia
Enrollment 1,000 participants
Start Date 2004-04-21
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-04